# Zepp Health Corp: overview ZEPP · NYSE · CIK 1720446 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/zepp.md) · [Financials](/companies/zepp/financials.md) · [Filings](/companies/zepp/filings.md) · [Insiders](/companies/zepp/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [981](/filings/0001104659-22-052369.md) | [614](/filings/0001410578-25-000903.md) | [353](/filings/0001104659-26-048127.md) | [183](/filings/0001104659-26-048127.md) | [259](/filings/0001104659-26-048127.md) | | Gross margin | % | [20.9%](/filings/0001104659-22-052369.md) | [19.4%](/filings/0001410578-25-000903.md) | [26.2%](/filings/0001104659-26-048127.md) | [38.5%](/filings/0001104659-26-048127.md) | [38.3%](/filings/0001104659-26-048127.md) | | Operating margin | % | [1.5%](/filings/0001104659-22-052369.md) | [(10.1%)](/filings/0001410578-25-000903.md) | [(8.6%)](/filings/0001104659-26-048127.md) | [(25.9%)](/filings/0001104659-26-048127.md) | [(11.3%)](/filings/0001104659-26-048127.md) | | Net margin | % | [2.2%](/filings/0001104659-22-052369.md) | [(7.0%)](/filings/0001410578-25-000903.md) | [(8.8%)](/filings/0001104659-26-048127.md) | [(41.5%)](/filings/0001104659-26-048127.md) | [(15.5%)](/filings/0001104659-26-048127.md) | | Diluted EPS | $ per share | [0.08](/filings/0001104659-22-052369.md) | [(0.18)](/filings/0001410578-25-000903.md) | [(0.13)](/filings/0001104659-26-048127.md) | [(0.29)](/filings/0001104659-26-048127.md) | [(0.16)](/filings/0001104659-26-048127.md) | | Free cash flow | $m | [(43.7)](/filings/0001104659-22-052369.md) | [(118)](/filings/0001410578-25-000903.md) | [41.0](/filings/0001104659-26-048127.md) | [(25.8)](/filings/0001104659-26-048127.md) | [(26.2)](/filings/0001104659-26-048127.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/zepp/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $3.9m | 741,834 | | Added +34,143 | | [FIL Ltd](/funds/318989.md) | 2026-06-30 | $3.7m | 718,178 | | Added +826 | | [Yiheng Capital Management, L.P.](/funds/1447228.md) | 2026-06-30 | $1.1m | 220,501 | | Added +162,770 | | [Allspring Global Investments Holdings, LLC](/funds/1890906.md) | 2026-06-30 | $243.6k | 46,748 | | Unchanged | | [CITIGROUP INC](/funds/831001.md) | 2026-06-30 | $208.4k | 40,000 | | Unchanged | | [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $157.9k | 30,309 | | Reduced −882 | | [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $136.3k | 26,153 | | New +26,153 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $134.4k | 25,800 | Put | Added +14,100 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $124.4k | 23,868 | | New +23,868 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $117.6k | 22,570 | | Reduced −11,753 | ## Recent filings [All 185 filings](/companies/zepp/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-02 | 06:03 ET | [6-K](/filings/0001104659-26-104424.md) | Report of a foreign private issuer, period 2026-09-02 | 0001104659-26-104424 | | 2026-06-09 | 06:02 ET | [6-K](/filings/0001104659-26-071539.md) | Report of a foreign private issuer, period 2026-06-09 | 0001104659-26-071539 | | 2026-04-24 | 07:26 ET | [20-F](/filings/0001104659-26-048127.md) | Annual report of a foreign private issuer, period 2025-12-31 | 0001104659-26-048127 | | 2026-03-16 | 06:03 ET | [6-K](/filings/0001104659-26-027831.md) | Report of a foreign private issuer, period 2026-03-16 | 0001104659-26-027831 | | 2025-11-05 | 06:03 ET | [6-K](/filings/0001104659-25-106586.md) | Report of a foreign private issuer, period 2025-11-05 | 0001104659-25-106586 | | 2025-08-04 | 06:01 ET | [6-K](/filings/0001104659-25-073254.md) | Report of a foreign private issuer, period 2025-08-04 | 0001104659-25-073254 | | 2025-05-20 | 06:05 ET | [6-K](/filings/0001104659-25-050677.md) | Report of a foreign private issuer, period 2025-05-20 | 0001104659-25-050677 | | 2025-04-25 | 08:14 ET | [20-F](/filings/0001410578-25-000903.md) | Annual report of a foreign private issuer, period 2024-12-31 | 0001410578-25-000903 | | 2025-03-27 | 06:07 ET | [6-K](/filings/0001104659-25-028396.md) | Report of a foreign private issuer, period 2025-03-27 | 0001104659-25-028396 | | 2024-11-19 | 06:01 ET | [6-K](/filings/0001104659-24-120316.md) | Report of a foreign private issuer, period 2024-11-19 | 0001104659-24-120316 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0001104659-26-048127.md), filed Apr 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1720446 - Tickers: ZEPP - Exchange: NYSE - SIC code: 3571 Electronic Computers - State of incorporation: E9 - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.